Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1985 Jul;48(7):639–644. doi: 10.1136/jnnp.48.7.639

A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.

N Callaghan, R A Kenny, B O'Neill, M Crowley, T Goggin
PMCID: PMC1028404  PMID: 3928820

Abstract

One hundred and eighty one patients with previously untreated epilepsy were randomised to sodium valproate, phenytoin or carbamazepine as monotherapy and followed up for a median period which ranged from 14 to 24 months. All three drugs were highly effective in the control of generalised seizures but less effective for partial seizures. Excellent or good control was achieved with therapeutic levels of sodium valproate and carbamazepine, but with subtherapeutic levels of phenytoin.

Full text

PDF
639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruni J., Albright P. Valproic acid therapy for complex partial seizures. Its efficacy and toxic effects. Arch Neurol. 1983 Mar;40(3):135–137. doi: 10.1001/archneur.1983.04050030029004. [DOI] [PubMed] [Google Scholar]
  2. Callaghan N., O'Callaghan M., Duggan B., Feely M. Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. J Neurol Neurosurg Psychiatry. 1978 Oct;41(10):907–912. doi: 10.1136/jnnp.41.10.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Callaghan N., O'Dwyer R., Keating J. Unnecessary polypharmacy in patients with frequent seizures. Acta Neurol Scand. 1984 Jan;69(1):15–19. doi: 10.1111/j.1600-0404.1984.tb07774.x. [DOI] [PubMed] [Google Scholar]
  4. Callaghan N., O'Hare J., O'Driscoll D., O'Neill B., Daly M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol. 1982 Dec;24(6):830–836. doi: 10.1111/j.1469-8749.1982.tb13703.x. [DOI] [PubMed] [Google Scholar]
  5. Covanis A., Gupta A. K., Jeavons P. M. Sodium valproate: monotherapy and polytherapy. Epilepsia. 1982 Dec;23(6):693–720. doi: 10.1111/j.1528-1157.1982.tb05085.x. [DOI] [PubMed] [Google Scholar]
  6. Herranz J. L., Arteaga R., Armijo J. A. Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients. Epilepsia. 1982 Apr;23(2):203–214. doi: 10.1111/j.1528-1157.1982.tb05068.x. [DOI] [PubMed] [Google Scholar]
  7. Jeavons P. M., Clark J. E. Sodium valproate in treatment of epilepsy. Br Med J. 1974 Jun 15;2(5919):584–586. doi: 10.1136/bmj.2.5919.584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kabra P. M., Stafford B. E., Marton L. J. Simultaneous measurement of phenobarbital, phenytoin, primidone, ethosuximide, and carbamazepine in serum by high-pressure liquid chromatography. Clin Chem. 1977 Jul;23(7):1284–1288. [PubMed] [Google Scholar]
  9. Kosteljanetz M., Christiansen J., Dam A. M., Hansen B. S., Lyon B. B., Pedersen H., Dam M. Carbamazepine vs phenytoin. A controlled clinical trial in focal motor and generalized epilepsy. Arch Neurol. 1979 Jan;36(1):22–24. doi: 10.1001/archneur.1979.00500370052010. [DOI] [PubMed] [Google Scholar]
  10. Rajotte P., Jilek W., Jilek L., Perales A., Giard N., Bordeleau J. M., Tétreault L. Propriétés antiépileptiques et psychotropes de la carbamazépine (Tégrétol) Union Med Can. 1967 Oct;96(10):1200–1206. [PubMed] [Google Scholar]
  11. Reynolds E. H., Chadwick D., Galbraith A. W. One drug (phenytoin) in the treatment of epilepsy. Lancet. 1976 May 1;1(7966):923–926. doi: 10.1016/s0140-6736(76)92709-4. [DOI] [PubMed] [Google Scholar]
  12. Reynolds E. H., Shorvon S. D. Monotherapy or polytherapy for epilepsy? Epilepsia. 1981 Feb;22(1):1–10. doi: 10.1111/j.1528-1157.1981.tb04327.x. [DOI] [PubMed] [Google Scholar]
  13. Shakir R. A., Johnson R. H., Lambie D. G., Melville I. D., Nanda R. N. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy. Epilepsia. 1981 Feb;22(1):27–33. doi: 10.1111/j.1528-1157.1981.tb04330.x. [DOI] [PubMed] [Google Scholar]
  14. Shorvon S. D., Chadwick D., Galbraith A. W., Reynolds E. H. One drug for epilepsy. Br Med J. 1978 Feb 25;1(6111):474–476. doi: 10.1136/bmj.1.6111.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Simonsen N., Olsen P. Z., Kühl V., Lund M., Wendelboe J. A comparative controlled study between carbamazepine and diphenylhydantoin in psychomotor epilepsy. Epilepsia. 1976 Jun;17(2):169–176. doi: 10.1111/j.1528-1157.1976.tb03394.x. [DOI] [PubMed] [Google Scholar]
  16. Troupin A., Ojemann L. M., Halpern L., Dodrill C., Wilkus R., Friel P., Feigl P. Carbamazepine--a double-blind comparison with phenytoin. Neurology. 1977 Jun;27(6):511–519. doi: 10.1212/wnl.27.6.511. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES